Business
ETST Acquires the Assets and Business of BEO-ITS, Inc., a Canadian Biotech Company Specializing in Medical Devices, Tests and Vaccines for Sexually Transmitted Infections and/or Diseases
ETST Acquires the Assets and Business of BEO-ITS, Inc., a Canadian Biotech Company Specializing in Medical Devices, Tests and Vaccines for Sexually Transmitted Infections and/or Diseases.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\n\n Boca Raton, Aug. 24, 2016 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (ETST) (the “Company”), a publicly traded biotechnology company that develops, produces and sells nutraceutical products along  with is its leading High Grade Hemp CBD (Cannabidiol) Oil, announces ETST has officially acquired substantially all of the assets and business of BEO ITS, Inc., a company engaged in the business of conceiving, creating, and marketing medical products, devices and methodologies including tests and vaccines for Sexually Transmitted Infections and/or Diseases. This asset purchase agreement of BEO ITS, Inc. includes the employment of its CEO and principal owner, Dr. Michel Aubé, which will be incorporated under ETST’s new wholly owned subsidiary, Earth Science Pharmaceutical, Inc., having Dr. Michel Aubé as the subsidiary CEO.\n Dr. Michel Aubé stated, “I am enthused to finally be a part of the ETST team. I’ve been working very hard the past 2 months with my Canadian network and team to help expedite the launch of Earth Science Pharmaceutical, Inc., a wholly owned subsidiary of Earth Science Tech, Inc. As the new CEO of Earth Science Pharmaceutical, Inc., I plan to build this company into a global leader in the development of low cost, non-invasive diagnostic tools, medical devices, and vaccines. We have a lot of exciting new developments to announce in the near future pertaining to the medical and pharmaceutical industry as well as CBD (Cannabidiol).” The United States remains the largest medical device market in the world with a market size of around $148 billion, and it is expected to reach $155 billion by 2017. The U.S. market value represented about 43 percent of the global medical device market in 2015. U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $44 billion in 2015. There are more than 6,500 medical device companies in the United States, mostly small and medium-sized enterprises (SMEs). Read more at https://www.selectusa.gov/medical-technology-industry-united-states.  Nickolas Tabraue, COO of Earth Science Tech, Inc. stated, “I’m thrilled that ETST closed the asset purchase of BEO ITS, Inc.  Dr. Michel Aubé brings extreme value to our company and team as he is both a well-div...